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Abstract
Background Non-steroidal anti-inflammatory drugs
(NSAIDs) are among the most widely used of all thera-
peutic agents. In spite of their therapeutic efficacy, concern
over the use of NSAIDs is largely related to their adverse
effects in different organic systems, as well as their
indiscriminate use. There is a lack of studies about the
pattern of use of NSAIDs in Portugal.
Objective The aim of this study was to characterize the
consumption pattern of NSAIDs by adult users in the
central region of Portugal, as well as the role of the com-
munity pharmacy professionals in counseling and pro-
moting their rational use.
Methods A questionnaire survey to determine sociode-
mographic information and NSAID use characterization
was administered to a sample of 450 pharmacy customers
between October and November of 2013.
Results The prevalence of NSAID use was 57.6 % (95 %
CI 53–62). Most of the 259 NSAID users were aged
18–39 years (61.4 %), female (67.6 %), urban zone
inhabitants (70.7 %) and practiced self-medication
(64.2 %). Self-medication with NSAIDs was significantly
(p B 0.001) related to age, employment status and the use
of gastroprotective drugs. The concomitant use of NSAIDs
and other medications revealed the possibility of drug
interactions in people aged C65 years (prevalence ratio
6.3). Of the NSAID users, 47 % reported that they some-
times, rarely or never received pharmacy professional
recommendations. However, the majority (76 %) of
respondents said that they read medicine leaflets, and
considered NSAIDs to be effective and remarkably safe.
Conclusions Considering the main results of this study, it
is imperative to promote the re-education of the population
and improve the consultative role of the pharmacy pro-
fessionals regarding NSAID use.
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are fre-
quently used worldwide to treat a large number of common
acute and chronic inflammatory conditions. These drugs
possess different chemical and clinical profiles, but essen-
tially exert the same therapeutic properties and are associ-
ated with similar adverse drug reactions (ADRs) [1–3].
Besides gastrointestinal injuries (the most common ADR
caused by this group) [4], there is evidence to link these
agents to toxicities affecting the cardiovascular [5, 6] and
renal [7] systems, as well as the liver [8]. Studies have
shown that both therapeutic and adverse effects of NSAIDs
are dependent on cyclo-oxygenase (COX) inhibition [9].
Indeed, the COX enzyme can be divided into two isoforms:
a constitutive and cytoprotective isoform (COX-1), which is
responsible for maintaining normal function in the gas-
trointestinal and renal tracts; and an inducible isoform
(COX-2), which is found in inflamed tissues. Traditional
NSAIDs inhibit both isoforms, while specific COX-2 inhi-
bitors have a substantially higher specificity for the COX-2
isoform, thus preserving the anti-inflammatory property of
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COX-2 inhibition and reducing the ADRs related to inhi-
bition to the COX-1 isoform, which results in a superior
gastrointestinal and renal safety profile when compared with
the non-selective COX inhibitors. However, COX-2 inhibi-
tors increase the risk of serious cardiovascular events [7].
In Portugal, according to the ‘‘Medicine and healthcare
products statistics 2014’’ compiled by the National
Authority of Pharmacy and Medicines (INFARMED),
NSAIDs were the eighth highest pharmacotherapeutic
subgroup with regard to the number of packages sold [10].
The statement is in line with another study, which showed
that NSAIDs placed fifth among chronically used medici-
nes and that they were used by 12–15 % of the study
participants [11]. Moreover, ADRs related to NSAID use,
especially gastrointestinal complications, continue to be
reported to the Portuguese Drug Prescription Vigilance
System, representing 11 % of overall reports, and often
causing hospitalization [12]. Similar results were obtained
in France [1] and Spain [13].
Physicians have a key role in evaluating the need for
anti-inflammatory therapies, and if deemed necessary, in
selecting and prescribing the most suitable currently
available NSAID, taking into account their tolerability
profiles and possible negative influence on health.
According to the European Medicine Agency’s Committee
on Medicinal Products for Human Use, NSAIDs should be
prescribed at the lowest effective dose and for the shortest
period necessary for symptom control [14]. Moreover,
individual risk factors and the possibility of individual
variability in response to NSAIDs must be considered by
practitioners to improve patient management [15].
Some NSAIDs can be purchased without prescription,
which allows patients to take responsibility for their therapy.
Therefore, pharmacy professionals have a key role to play in
counseling and promoting the appropriate selection of
NSAIDs, as they are the last link to patients beforeNSAIDuse.
The absence of data reflecting the prevalence and pat-
tern of use of NSAIDs in the Portuguese population, and
the attitudes and knowledge of healthcare providers,
namely pharmacy professionals, towards the promotion of
their rational use, has prompted the undertaking of this
study. A survey, using an investigator-administered ques-
tionnaire, was conducted in the central region of Portugal
in order to evaluate NSAID use by the adult population, to
characterize NSAIDs users, and to evaluate the role of
community pharmacy professionals in NSAID use.
Materials and methods
This was a cross-sectional study, with a questionnaire
survey developed by the authors being used as the data
collection instrument. Data collection took place in
community pharmacies in the Portuguese districts of
Aveiro, Castelo Branco, Guarda and Viseu between
October and November of 2013. As this is an observational
study, based on the results of a survey, no formal approval
from any committee was required.
The target population included all adults aged[18 years
who were residents of the Portuguese districts of Aveiro,
Castelo Branco, Guarda and Viseu. According to the 2011
Portuguese National Statistics Institute census, the base
population in these districts was 847,581. Based on this
population and a sampling error of 5 % plus 12.5 % to
cover possible non-response, the estimated total sample
size was 450 (using the Taro Yamane equation). The
sample was stratified to reflect the proportional population
of each district, resulting in 170 participants from Aveiro,
76 from Castelo Branco, 75 from Guarda and 129 from
Viseu. Respondents, aged[18 years and resident in one of
the four districts, participated voluntarily and anony-
mously, and were informed of the scope and objectives of
the study. The survey of pharmacy customers was con-
ducted by personal interview (mean duration 15 min), with
a single investigator recording the answers in a printed
questionnaire in order to avoid errors that could lead to
invalid answers. The researchers contacted all pharmacies
in each district and obtained permission from a group of
pharmacies to interview their customers within a given
time period, thereby obtaining a convenience sample. To
obtain the 450 completed surveys, it was necessary to
request the participation of 502 individuals.
The questionnaire survey was developed using a sys-
tematic approach, with the objectives of being concise and
easy to understand. After pre-testing the survey in eight
individuals from the target population, changes were made
in the text of some questions in order to improve under-
standing. The survey had two parts, and included closed
questions, with single or multiple choice responses, and
one question with an open response. The first part inquired
about the sociodemographic characteristics of respondents,
and the second asked about their health status and NSAID
use, focusing primarily on issues relating to their pattern of
consumption of NSAIDs. Respondents were asked if they
had taken NSAIDs in the last 6 months; only those par-
ticipants who had taken NSAIDs in the last 6 months
answered the remaining survey questions, which were
related to the identification of used NSAIDs and factors
associated with their consumption. The recall period of
6 months was chosen to obtain data regarding recent
NSAID use. Individuals who had taken NSAIDs in the last
6 months indicated which NSAIDs they had used from a
list of drugs (including brand-names), the signs and
symptoms that motivated their use, and whether or not the
individual had a prescription for the NSAID, received
recommendations from pharmacy professionals when the
NSAID was acquired, knew the adverse effects of the
NSAID or had read the NSAID-related leaflets.
Descriptive data analysis provided the sociodemo-
graphic characterization and description of health status
and usage profile issues of the sample. The Fisher’s exact
test was used for dichotomous variables. Pearson’s Chi-
squared test and, in other cases, the prevalence ratio (PR)
and its 95 % confidence interval (CI) were applied to study
the association between qualitative variables. There was
also the comparison of means (t test for two independent
samples), in the case of a quantitative variable, to com-
plement the association study. The results were analyzed
for a significance level of 5 %. Data processing and anal-
ysis were conducted using Google Drive and SPSS version
20.
Results
With regard to the sociodemographic characteristics of the
450 respondents (Table 1), the data indicated that the
majority lived in an urban zone (66 %), were female
(63 %), were young adults aged between 18 and 39 years
(58 %) and had a civil status of married/civil partnership or
single (91 %). Regarding academic qualifications and
employment status, 64 % of respondents did not have
higher education (diploma course/bachelor or higher), and
33 % had no income or had low income (house-
wife/househusband, students and unemployed), with the
remaining 67 % being retired, employers and dependent or
independent workers. Of note, the professional activities
with the largest representation in the sample were related to
health (17 %), technology (11 %) and economics, man-
agement and accounting (11 %). A third of respondents
(34 %) reported having a chronic disease, most commonly
hypertension, hypercholesterolemia, diabetes and muscu-
loskeletal system problems.
In order to understand the attitude of individuals towards
the use of common drugs, the survey included questions
regarding the consultation of medicine leaflets. The
majority of respondents (343; 76.2 %) read the medicine
leaflet, which might indicate that they considered the
information it contained to be important.
When respondents were asked about the consumption of
NSAIDs in the last 6 months, 259 (57.6 %; 95 % CI
53.0–62.2) provided an affirmative answer to the question,
with these respondents using an average of 1.7 (95 % CI
1.6–1.8) NSAIDs. The remaining 191 respondents
(42.4 %) had not used an NSAID in the past 6 months
(Fig. 1) and, therefore, were not asked to complete the rest
of the questionnaire.
Based on the sociodemographic characteristics of the
259 NSAIDs users (Table 1), most were aged 18–39 years
(61.4 %), female (67.6 %), urban zone inhabitants
(70.7 %) and involved in health study or labor activity
(21.6 %).
According to the answers to the question ‘‘Which
NSAIDs did you consume?’’ ibuprofen was the most com-
monly used (188; 72.6 %), followed by diclofenac (79;
30.5 %) and nimesulide (58; 22.4 %) [Fig. 2]. The NSAIDs
referred to by one or two respondents (i.e. aceclofenac,
bendazac, celecoxib, dexibuprofen, etodolac, naproxen,
piroxicam, bendazac, ketoprofen, dexketoprofen, fenbufen,
flufenamic acid, symphytum officinale and diethylamine
salicylate plus sodium heparin plus menthol) were counted
together and classified as ‘‘others’’ (19; 7.3 %).
For the most commonly used NSAIDs, the number of
daily doses administered varied, with 108 respondents
(41.7 %) taking the NSAID once daily, 102 (39.4 %) twice
daily, 43 (16.6 %) three times daily and 6 (2.3 %) more
than three times per day. Of note, 35 (13.5 %) of NSAID
users responded that they had used two NSAIDs
simultaneously.
The most commonly used NSAID dosage form was
solid oral preparations (228 respondents; 88 %), followed
by cutaneous and transdermal forms (78; 30.1 %), oral
solutions/suspensions (29; 11.2 %), gingival/buccal solu-
tions (27; 10.4 %) and, finally, parenteral preparations (4;
1.5 %) [individuals could use more than one dosage form].
The majority of respondents (234; 90.3 %) took NSAIDs
during or after meals, and the remaining 25 (9.7 %) took
the medication at a non-recommended time (7.4 % took it
before meals and 2.3 % fasting), which might worsen the
adverse effects of these drugs. Most NSAID users (218;
84.2 %) took NSAIDs for up to 5 days and the remaining
41 users (15.8 %) for longer than 5 days.
Considering that the use of NSAIDs could lead to gas-
trointestinal damage, a gastroprotective agent is usually co-
prescribed, although its use, suitability, effectiveness and
safety should be considered [16]. Most NSAID users (217;
83.8 %) did not use a gastroprotector. Of the 42 users
(16.2 %) who did, most used proton pump inhibitors
(PPIs), including omeprazole, pantoprazole and
esomeprazole (29, seven and two users, respectively); the
anti-ulcer drug sucralfate was used by two patients, and
other gastroprotective drugs, such as histamine H2-receptor
antagonists, were less frequently used.
Respondents were requested to indicate the signs and
symptoms that motivated the use of NSAIDs (Fig. 3).
Headaches were the motivation reported by 113 (43.6 %)
of NSAID users. Most respondents used NSAIDs for pain
associated with musculoskeletal system, with emphasis on
joint pain (73 respondents; 28.2 %), backache pain (66;
25.5 %), pain in the limbs (56; 21.6 %), body pain (34;
13.1 %) or pain associated with fracture or trauma (19;
7.3 %).
As for the improvements felt after taking NSAIDs, 245
(94.6 %) respondents who used NSAIDs in the past
6 months said they felt improvements, which points out the
effectiveness of these medicines. There was no association
Fig. 1 Distribution of the number of non-steroidal anti-inflammatory
drugs (NSAIDs) consumed in the last 6 months
Fig. 2 Percentage of respondents who used non-steroidal anti-
inflammatory drugs (NSAIDs)
Table 1 Sociodemographic characteristics of respondents (n = 450)








Female 175 108 283 (63)
Male 84 83 167 (37)
Residence zone
Urban 183 115 298 (66)
Rural 76 76 152 (34)
Age (years)
18–29 102 73 175 (39)
30–39 57 29 86 (19)
40–49 25 27 52 (12)
50–64 47 40 87 (19)
C65 28 22 50 (11)
Civil status
Single 112 88 200 (44)
Married/civil partnership 124 86 210 (47)
Divorced 12 7 19 (4)




4 5 9 (2)
1st cycle of basic
education
32 20 52 (12)
2nd cycle of basic
education
9 13 22 (5)
3rd cycle of basic
education
27 28 55 (12)
High school 88 61 149 (33)
Diploma/bachelors
degree
11 7 18 (4)
Graduate 76 48 124 (28)
Masters degree 11 7 18 (4)
PhD 1 2 3 (1)
Employment status
Unemployed 29 27 56 (12)
Independent worker 19 12 31 (7)
Dependent worker 110 77 187 (42)
Student 51 34 85 (19)
Retired 40 35 75 (17)
Employer 7 3 10 (2)
Housewife/househusband 3 3 6 (1)
Area of study or labor
Science 14 18 32 (7)
Health 56 21 77 (17)
Technology 28 22 50 (11)
Agriculture/natural
resources
5 9 14 (3)
Table 1 continued







Architecture/arts/design 4 3 7 (2)
Educational sciences/
teacher education
26 16 42 (9)
Law/social sciences/
services
17 19 36 (8)
Economics/management/
accounting
29 19 48 (11)
Humanities/
administration/translation
29 12 41 (9)
Physical education/sport/
performing arts
5 6 11 (2)
Domestic worker 10 12 22 (5)
Retail/restaurant workers 26 24 50 (11)
Factory worker 10 10 20 (4)
NSAID non-steroidal anti-inflammatory drugs
(p = 0.119) between the improvement of health status and
duration (up to 5 days or longer than 5 days) of NSAID
treatment. Of the 218 respondents who had been treated for
up to 5 days, 207 (95.0 %) said that their health status had
improved, indicating that short-term treatment with
NSAIDs is generally effective.
With regard to whether individuals were prescribed
NSAIDs or were self-medicating, 165 of 257 (64.2 %)
NSAID users who answered this question practiced self-
medication.
Based on an ordinal scale of the frequency of recom-
mendations from pharmacy professionals about how to take
the medicine, 79 (30.5 %) of NSAID users frequently
received recommendations, 58 (22.4 %) always received
recommendations and 44 (17 %) sometimes received rec-
ommendations. However, [30 % of NSAID users never
(53; 20.5 %) or rarely (25; 9.6 %) received recommenda-
tions given by the pharmacy professional. The 181 NSAID
users who sometimes, frequently or always received
pharmacy professional recommendations were asked to
identify the recommendations. The answers were analyzed,
processed and standardized. The distribution of answers is
shown in Fig. 4. The timing of doses (78 responses; 30.1 %
of answers); daily recommended dose (55; 21.2 %) and
posology (52; 20.1 %) were the most frequently mentioned
recommendations.
Of the 259 NSAID users, 233 (90.0 %) said that they did
not have any complications after taking these drugs.
However, 14 respondents (5.4 %) reported nausea, nine
(3.5 %) diarrhea, six (2.3 %) difficulty in digestion and
only two (0.8 %) other ADRs, such as vomiting and
heartburn (some individuals reported more than one ADR).
The individuals were questioned about the concomitant
use of other medications with NSAIDs, as drug interactions
could arise. Most NSAIDs users (159; 61.4 %) did not use
NSAIDs simultaneously with other medications, while 100
(38.6 %) said that they took one or more medications at the
same time. Of these 100 individuals, 31 % indicated the
simultaneous use of antihypertensives, 6 % anticoagulants
and 5 % digoxin, and the majority (58 %) chose the survey
option ‘other’ and mentioned a lipid-lowering, antidiabetic
or analgesic drug; 54 % of these respondents said that the
pharmacy professional had knowledge that they did so,
with the remaining 46 % stating that the professionals did
not have this information. NSAIDs were used concomi-
tantly with other medications by 24 of the 27 individuals
aged C65 years (PR 6.3; 95 % CI 2.2–18.3), but only by 69
of the 227 individuals aged \65 years, indicating that
elderly patients are more likely to use NSAIDs with other
medications.
NSAIDs are contraindicated in certain situations/condi-
tions. Of the NSAID users, 202 (78 %) did not report any
pathology. The remaining 57 NSAID users (22 %) had one
or more clinical situations in which taking NSAIDs is
contraindicated: 34 respondents with hypertension, eight
with heart failure, eight with renal failure, seven with
active peptic ulcer, four who were pregnant or breast-
feeding and one with hypersensitivity to constituents.
An evaluation of the possible association between
NSAID use in the last 6 months and the sociodemographic
characteristics of respondents indicated that there was a
statistically significant association with gender
(p = 0.018), with women consuming more NSAIDs than
men (PR 1.2), and residence zone (p = 0.026), with those
living in an urban zone consuming more NSAIDs than
those in rural zones (PR 1.2) [Table 2]. The latter result
might be related to how easy it is to acquire NSAIDs in the
urban zone and to the lifestyle of these residents. The
average number of NSAIDs used was also significantly
higher in women (p = 0.009) and in the urban zone
(p = 0.018), but there were no significant differences
between the number of drugs used and the professional
situation or educational level.
There was a significant association between NSAID use
in the last 6 months and reading the information contained
in the medicine leaflet (p = 0.005; PR 1.3) [Table 2].
Fig. 3 Signs and symptoms that motivated the use of non-steroidal
anti-inflammatory drugs (NSAIDs)
Fig. 4 Advice given by the pharmacy professional
There was also a significant (p\ 0.001) association
between reading the medicine leaflet and gender (PR 1.4
for women vs. men) and age (PR 1.1 for individuals aged
18–29 years, 1.2 for those aged 30–39 years and 0.6 for
those aged C65 years) [Table 3].
Self-medication with NSAIDs was significantly associ-
ated with only two sociodemographic variables, namely
age (p\ 0.001) and employment status (p = 0.001). Self-
medication was more common in individuals aged
\40 years (PR 1.4 for individuals aged 18–29 years and
1.1 for those aged 30–39 years) [Table 4], with this prac-
tice less frequent in older age groups. Retired people and
housewife/househusband acquired NSAIDs by prescription
(PR for both 0.5), whereas the unemployed were more
likely to self-medicate (PR 1.3). Importantly, a significant
(p\ 0.001) association between self-medication with
NSAIDs and the use of gastroprotective drugs was found,
with individuals who self-medicated being more unlikely
to take a gastroprotective drug when taking NSAIDs (PR
0.6) compared with those who got NSAIDs by prescription
(PR 2).
Discussion
In our study, the prevalence rate of NSAID use was 57.6 %
(95 % CI 53–62.2), which is comparable with that in the
scientific literature and medicine consumption studies of
the Portuguese Health National Authority, showing a high
level of consumption of this group of medicines. Ibuprofen
was the drug that had the highest rate of use, followed by
diclofenac and nimesulide. Of the top 50 active substances
with the highest number of packages sold in the Portuguese
National Health System, ibuprofen was in ninth place and
diclofenac was in twenty-seventh place [10]. This con-
sumption tendency was also reported by other studies
[17–19]. However, in a study conducted in Serbia [20],
diclofenac accounted for &50 % of NSAID consumption
Table 2 Association between NSAID consumption in the last 6 months and gender, residence zone and reading the medicine leaflet (n = 450)
Characteristic No. of respondents (%a) Statistical analysis
NSAID users Non-NSAID users P value Prevalence ratio (95 % CI)
Association between NSAID use and gender
Female 175 (61.8) 108 (38.2) 0.018 1.2 (1.0–1.5)
Male 84 (50.3) 83 (49.7)
Association between NSAID use and residence zone
Urban 183 (61.4) 115 (38.6) 0.026 1.2 (1.0–1.5)
Rural 76 (50.0) 76 (50.0)
Association between NSAID use and reading the medicine leaflet
Leaflet readers 210 (61.2) 133 (38.8) 0.005 1.3 (1.1–1.7)
Leaflet non-readers 49 (45.8) 58 (54.2)
NSAID non-steroidal anti-inflammatory drugs
a Percentages refer to the total individuals in the category represented by row
Table 3 Association between reading the medicine leaflet and gender and age (n = 450)
Characteristic No. of respondents (%a) Statistical analysis
Leaflet readers Non-leaflet readers P value Prevalence ratio (95 % CI)
Association between reading the leaflet and gender
Female 243 (85.9) 40 (14.1) \0.001 1.4 (1.3–1.6)
Male 100 (59.9) 67 (40.1)
Association between reading the leaflet and age (years)
18–29 139 (79.4) 36 (20.6) \0.001 1.1 (1.0–1.2)
30–39 76 (88.4) 10 (11.6) 1.2 (1.1–1.3)
40–49 39 (75.0) 13 (25.0) 1 (0.8–1.2)
50–64 64 (73.6) 23 (26.4) 1 (0.8–1.1)
C65 25 (50.0) 25 (50.0) 0.6 (0.5–0.8)
a Percentages refer to the total individuals in the category represented by row
during the observation period, followed (in much smaller
quantities) by ibuprofen.
Of the 259 NSAID users in our study, 83.8 % did not
consume any gastroprotective agent and 16.2 % used gas-
troprotective drugs, primarily omeprazole. In a general
practitioner-based survey in France that evaluated gastro-
protective drug co-prescription, 29.5 % of NSAID pre-
scriptions included a gastroprotective agent, with
omeprazole accounting for 58 % of these co-prescriptions
[21]. In a similar study conducted in Portugal, the pro-
portion of patients taking gastroprotective drugs was 40 %,
with PPIs being the most commonly used [12]. In fact, in
our study the proportion was lower (16.2 %) than 40 %
and, as stated by the authors [12], the percentage obtained
was a result of an interview perception on an ‘‘intention-to-
treat basis’’ and might be an overestimation.
The practice of taking NSAIDs concomitantly with
other medications was more common in older individuals,
with 89 % of individuals aged C65 years doing so. This
may be due to the fact that the elderly population had
chronic pathologies and, as such, practiced polypharmacy
[22].
Almost half of the sample (43.6 %) considered head-
aches the reason for taking NSAIDs. A study conducted in
Italy [23] also found that NSAIDs were frequently used to
treat painful and non-inflammatory conditions (e.g. head-
ache, unspecified pain, etc.) that could be treated with other
first-line treatments. ADRs were reported by only 10.1 %
of respondents. NSAIDs have high acceptability, but are
associated with cardiovascular and gastrointestinal ADRs,
especially at the highest and most efficacious dosages [5].
Nonetheless, as NSAID use is episodic and limited to
shorter periods, the respondents could not relate the
adverse effects to these medicines.
Furthermore, despite the low (22 %) proportion of
respondents who had contraindications to the use of
NSAIDs, it is important to closely supervise and monitor
the use of NSAIDs, especially in high-risk patients.
About 70 % of the individuals said they received rec-
ommendations from pharmacy professionals about NSAID
use, which were primarily concerned with NSAID admin-
istration. Similar conclusions were made in a study con-
ducted in Thailand [24], where the authors stressed that
patients received NSAID information mostly from health-
care professionals, but safety information was limited.
Self-medication represents an important public health
issue, but little data exists regarding its risk [25]. In this
study, 64.2 % of respondents practiced self-medication
with NSAIDs. A study conducted in Italy reported a
comparable high proportion (44 %) of NSAID self-medi-
cation [23].
With respect to counseling by pharmacy professionals,
our study showed that there are still some flaws, as a high
proportion of NSAID users reported rarely or never having
Table 4 Association between self-medication with NSAIDs and age, professional status and gastroprotection
Characteristic No. of respondents (%a) Statistical analysis
Self-medicators Non-self-medicators P value Prevalence ratio (95 % CI)
Association between self-medication with NSAIDs and age (years)
18–29 79 (78.2) 22 (21.8) \0.001 1.4 (1.2–1.7)
30–39 40 (71.4) 16 (28.6) 1.1 (1.1–1.4)
40–49 14 (56.0) 11 (44.0) 0.9 (0.8–1.2)
50–64 21 (44.7) 26 (55.3) 0.7 (0.8–1.1)
C65 11 (39.3) 17 (60.7) 0.6 (0.5–0.8)
Association between self-medication and employment status
Unemployed 23(79.3) 6 (20.7) 0.001 1.3 (1.0–1.6)
Independent worker 12(63.2) 7 (36.8) 1 (0.7–1.4)
Dependent worker 75 (69.4) 33 (30.6) 1.1 (1.0–1.4)
Student 36 (70.6) 15 (29.4) 1.1 (0.9–1.4)
Retired 14 (35.0) 26 (65.0) 0.5 (0.3–0.8)
Employer 4 (57.1) 3 (42.9) 0.9 (0.5–1.8)
Housewife/househusband 1 (33.3) 2 (66.7) 0.5 (0.1–2.6)
Association between self-medication with NSAIDs and concomitant use of gastroprotective drugs
Use 16 (39.0) 25 (61.0) \0.001 0.6 (0.4–0.8)
Do not use 149 (69.0) 67 (31.0) 2 (1.4–2.7)
NSAID non-steroidal anti-inflammatory drugs
a Percentages refer to the total individuals in the category represented by row
received any recommendation for their rational consump-
tion. As NSAIDs are usually used in a regimen of self-
medication, a certain negligence was attributed to the
community pharmacy professionals with regard to their
dispensation, counseling and education of users as to how
to promote the correct use of these medicines in order to
assure quality, efficacy and safety and, especially, to alert
users to severe complications. Moreover, individuals who
practice NSAID self-medication are less likely to take
gastroprotective drugs.
There are some limitations in our work. Foremost, we
did not get a randomized sample and, therefore, the sample
may not be representative of the target population. How-
ever, the personal interview technique increases the
response rate, which increases the likelihood that everyone
in our population is represented. Regarding the character-
ization of the pattern of NSAID use, two issues were
identified. Firstly, the period considered for NSAID use
(last 6 months) could lead to a subestimation of prevalence,
as respondents could not precisely report NSAID use in this
period, and it was not possible to distinguish between
incident and prevalent users. Secondly, even when shown
the list of all NSAIDs and their brand-names, some
respondents did not remember the name of the NSAID. As
a personal interview was conducted, it was possible to
address this issue in part, because the researcher could help
respondents to remember some details that allowed the
NSAID’s identification.
Conclusions
This study investigated the profile of NSAID use by adult
pharmacy customers in the central region of Portugal and
assessed the role of pharmacy professionals in promoting the
rational use of these medicines, through the use of a struc-
tured interview. The surveyed sample revealed many short-
comings in the knowledge about the indications and
complications associated with NSAID use. A high propor-
tion of NSAID users rarely or never received recommenda-
tions on NSAID use from pharmacy professionals.
Furthermore, the majority of NSAIDs users practiced self-
medication, with this population being less likely to take
gastroprotective drugs. Therefore, an urgent re-education of
the population regardingNSAIDuse is needed.NSAIDusers
at high risk of ADRs should bemonitored and their treatment
regimens appropriately tailored. Pharmacy professionals
should re-evaluate their conduct regarding counseling and
recommendations pertaining toNSAIDs, with the purpose of
promoting the rational use of this group of medicines.
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18. Horvat O, Mijatović V, Čalasan J, et al. Outpatient utilization of
non-steroidal anti-inflammatory drugs in three largest munici-
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